drugset / Trial / NCT01159379
Safety of Ertapenem in Beta-lactam Allergic Patients.
Phase 4
Unknown
30 enrolled
Catholic University of the Sacred Heart
Merck Sharp & Dohme LLC · collab
NaSingle-groupOpen-label
Summary
The purpose of this study is to assess cross-reactivity and tolerability of ertapenem in patients with IgE-mediated allergy to at least one beta-lactam molecule.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-09
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ertapenem | Small molecule | 1 g | Intravenous |